Oncology Bulletin

Oncology Bulletin


Editor's top 3 picks

AACR Annual Meeting 2024: news roundup

Read the latest news from the AACR 2024 Annual Meeting. Highlights include the PETRA trial, which has highlighted the potential of selective PARP inhibitors and a study exploring how drugs granted US FDA accelerated approval have performed. Catch up here!


The American Society of Clinical Oncology (ASCO) has issued comprehensive guidelines on vaccinating adults with solid tumors or hematologic malignancies to prevent or reduce the severity of infection. Read more here.


A journey through value-based oncology care

In this interview, we speak with Chevon Rariy (Chief Health Officer & SVP of Digital Health at Oncology Care Partners, AZ, USA) about how artificial intelligence (AI) and value-based care could influence healthcare delivery to create better care journeys for cancer patients.


要查看或添加评论,请登录

Oncology Central的更多文章

社区洞察

其他会员也浏览了